FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978143312> ?p ?o ?g. }

• W1978143312 endingPage "406" @default.
• W1978143312 startingPage "395" @default.
• W1978143312 abstract "Abstract The mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase that exists in two complexes (mTORC1 and mTORC2) and integrates extracellular and intracellular signals to act as a master regulator of cell growth, survival, and metabolism. The PI3K/AKT/mTOR prosurvival pathway is often dysregulated in multiple sarcoma subtypes. First-generation allosteric inhibitors of mTORC1 (rapalogues) have been extensively tested with great preclinical promise, but have had limited clinical utility. Here, we report that MLN0128, a second-generation, ATP-competitive, pan-mTOR kinase inhibitor, acts on both mTORC1 and mTORC2 and has potent in vitro and in vivo antitumor activity in multiple sarcoma subtypes. In vitro, MLN0128 inhibits mTORC1/2 targets in a concentration-dependent fashion and shows striking antiproliferative effect in rhabdomyosarcoma (RMS), Ewing sarcoma, malignant peripheral nerve sheath tumor, synovial sarcoma, osteosarcoma, and liposarcoma. Unlike rapamycin, MLN0128 inhibits phosphorylation of 4EBP1 and NDRG1 as well as prevents the reactivation of pAKT that occurs via negative feedback release with mTORC1 inhibition alone. In xenograft models, MLN0128 treatment results in suppression of tumor growth with two dosing schedules (1 mg/kg daily and 3 mg/kg b.i.d. t.i.w.). At the 3 mg/kg dosing schedule, MLN0128 treatment results in significantly better tumor growth suppression than rapamycin in RMS and Ewing sarcoma models. In addition, MLN0128 induces apoptosis in models of RMS both in vitro and in vivo. Results from our study strongly suggest that MLN0128 treatment should be explored further as potential therapy for sarcoma. Mol Cancer Ther; 14(2); 395–406. ©2014 AACR." @default.
• W1978143312 created "2016-06-24" @default.
• W1978143312 creator A5001610703 @default.
• W1978143312 creator A5004111432 @default.
• W1978143312 creator A5006913373 @default.
• W1978143312 creator A5007697804 @default.
• W1978143312 creator A5022744236 @default.
• W1978143312 creator A5031037291 @default.
• W1978143312 date "2015-02-01" @default.
• W1978143312 modified "2023-10-12" @default.
• W1978143312 title "MLN0128, an ATP-Competitive mTOR Kinase Inhibitor with Potent <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity, as Potential Therapy for Bone and Soft-Tissue Sarcoma" @default.
• W1978143312 cites W1492255477 @default.
• W1978143312 cites W1494244942 @default.
• W1978143312 cites W1592142762 @default.
• W1978143312 cites W1980396381 @default.
• W1978143312 cites W1983698019 @default.
• W1978143312 cites W1988338260 @default.
• W1978143312 cites W1990749424 @default.
• W1978143312 cites W1992170852 @default.
• W1978143312 cites W1998762942 @default.
• W1978143312 cites W1998763810 @default.
• W1978143312 cites W1999999605 @default.
• W1978143312 cites W2000110198 @default.
• W1978143312 cites W2012142261 @default.
• W1978143312 cites W2029348880 @default.
• W1978143312 cites W2029758372 @default.
• W1978143312 cites W2045178199 @default.
• W1978143312 cites W2054780042 @default.
• W1978143312 cites W2055606489 @default.
• W1978143312 cites W2063013559 @default.
• W1978143312 cites W2074708554 @default.
• W1978143312 cites W2076033933 @default.
• W1978143312 cites W2077737742 @default.
• W1978143312 cites W2080238287 @default.
• W1978143312 cites W2084020418 @default.
• W1978143312 cites W2095949683 @default.
• W1978143312 cites W2102148658 @default.
• W1978143312 cites W2104932289 @default.
• W1978143312 cites W2114492564 @default.
• W1978143312 cites W2116761906 @default.
• W1978143312 cites W2117028091 @default.
• W1978143312 cites W2119151801 @default.
• W1978143312 cites W2121425239 @default.
• W1978143312 cites W2126783165 @default.
• W1978143312 cites W2127736279 @default.
• W1978143312 cites W2130253344 @default.
• W1978143312 cites W2134410951 @default.
• W1978143312 cites W2135504026 @default.
• W1978143312 cites W2136923108 @default.
• W1978143312 cites W2137853367 @default.
• W1978143312 cites W2143912677 @default.
• W1978143312 cites W2152589884 @default.
• W1978143312 cites W2154836325 @default.
• W1978143312 cites W2156768359 @default.
• W1978143312 cites W2157382176 @default.
• W1978143312 cites W2158193323 @default.
• W1978143312 cites W2163239105 @default.
• W1978143312 cites W2163583831 @default.
• W1978143312 cites W2165534057 @default.
• W1978143312 cites W2165848665 @default.
• W1978143312 cites W2388163742 @default.
• W1978143312 doi "https://doi.org/10.1158/1535-7163.mct-14-0711" @default.
• W1978143312 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4332837" @default.
• W1978143312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25519700" @default.
• W1978143312 hasPublicationYear "2015" @default.
• W1978143312 type Work @default.
• W1978143312 sameAs 1978143312 @default.
• W1978143312 citedByCount "82" @default.
• W1978143312 countsByYear W19781433122015 @default.
• W1978143312 countsByYear W19781433122016 @default.
• W1978143312 countsByYear W19781433122017 @default.
• W1978143312 countsByYear W19781433122018 @default.
• W1978143312 countsByYear W19781433122019 @default.
• W1978143312 countsByYear W19781433122020 @default.
• W1978143312 countsByYear W19781433122021 @default.
• W1978143312 countsByYear W19781433122022 @default.
• W1978143312 countsByYear W19781433122023 @default.
• W1978143312 crossrefType "journal-article" @default.
• W1978143312 hasAuthorship W1978143312A5001610703 @default.
• W1978143312 hasAuthorship W1978143312A5004111432 @default.
• W1978143312 hasAuthorship W1978143312A5006913373 @default.
• W1978143312 hasAuthorship W1978143312A5007697804 @default.
• W1978143312 hasAuthorship W1978143312A5022744236 @default.
• W1978143312 hasAuthorship W1978143312A5031037291 @default.
• W1978143312 hasBestOaLocation W19781433121 @default.
• W1978143312 hasConcept C107846503 @default.
• W1978143312 hasConcept C11960822 @default.
• W1978143312 hasConcept C142724271 @default.
• W1978143312 hasConcept C150903083 @default.
• W1978143312 hasConcept C184235292 @default.
• W1978143312 hasConcept C185592680 @default.
• W1978143312 hasConcept C207001950 @default.
• W1978143312 hasConcept C2778256501 @default.
• W1978143312 hasConcept C502942594 @default.
• W1978143312 hasConcept C55493867 @default.
• W1978143312 hasConcept C62478195 @default.
• W1978143312 hasConcept C71924100 @default.
• W1978143312 hasConcept C75217442 @default.

• next